Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults

Mayo Clinic Proceedings

Volumn 77, Issue 3, 2002, Pages 226-231

  Chatrath, Ritu ^a   Porter, Co Burn J ^a   Ackerman, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

ARVD = arrhythmogenic right ventricular dysplasia; DFT = defibrillation threshold; HCM = hypertrophic cardiomyopathy; ICD = implantable cardioverter defibrillator; LQTS = long QT syndrome; OHCA = out of hospital cardiac arrest; QTc = corrected QT interval; VF = ventricular fibrillation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD CARE; CLINICAL ARTICLE; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANT; IMPLANTATION; LONG QT SYNDROME; MALE; PRIMARY PREVENTION; SCHOOL CHILD; SUDDEN DEATH; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036181111     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.3.226     Document Type: Article

References (23)

1. Sudden death from cardiac causes in children and young adults
2. Outcome of out-of-hospital cardiac or respiratory arrest in children
3. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients
4. Preliminary experience with nonthoracotomy implantable cardioverter defibrillators in young patients
5. Five-year experience with implantable defibrillators in children
6. Implantable cardioverter-defibrillators in children: A single-institutional experience
7. The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction
8. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings
9. Initial clinical experience with a new down-sized implantable cardioverter-defibrillator
10. Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators
11. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults
12. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
13. Arrhythmogenic right ventricular cardiomyopathy: Diagnosis, prognosis, and treatment
14. Idiopathic long QT syndrome: Progress and questions
15. Effectiveness and limitations of β-blocker therapy in congenital long-QT syndrome
16. The long QT syndrome in children: An international study of 287 patients
17. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome
18. The long QT syndrome: Ion channel diseases of the heart
19. Long-term follow-up of patients with long-QT syndrome treated with β-blockers and continuous pacing
20. The implantable cardioverter defibrillator
21. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants
22. Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review
23. Young at heart: Understanding the unique psychosocial adjustment of young implantable cardioverter defibrillator recipients